GSK deal aims to discover new oncology treatments

OXFORD: GSK has agreed an acquisition worth up to $1.15 billion for IDRx, an American…

To read the full content…SUBSCRIBE NOW

Existing Subscribers Login Below:

Log In



Already a member? Log in here